Arbutus Biopharma Corp. (ABUS)
4.235
-0.12
(-2.64%)
USD |
NASDAQ |
May 15, 14:06
Arbutus Biopharma EPS Diluted (Quarterly) : 0.8693 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -3.40 |
| Vertex Pharmaceuticals, Inc. | 4.024 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 169.70M |
| Revenue (Quarterly) | 179.13M |
| Total Expenses (Quarterly) | 9.431M |
| Enterprise Value | 767.97M |
| Gross Profit Margin (Quarterly) | 99.99% |
| Profit Margin (Quarterly) | 94.74% |
| Earnings Yield | 19.42% |
| Operating Earnings Yield | 18.98% |
| Normalized Earnings Yield | 19.31 |